Robin Coleman

Piedmont Pharmaceuticals, Inc. develops animal veterinary pharmaceutical products. It also focuses on human and animal health therapeutics. The firm out-licenses domestic and worldwide product marketing rights to strategically-pharmaceutical partners. The company was founded by Roland H. Johnson in 2001 and is headquartered in Greensboro, NC.

Altiris Therapeutics, Inc. develops and commercializes small-molecule drug therapies. The company was founded by Dennis Liotta, Hyunsuk Shim and James P. Snyder in 2005 and is headquartered in Atlanta, GA.

Lake Technology Ltd. develops and markets digital signal processing systems and algorithms used in audio applications including live concert sound, consumer entertainment products, personal computers, in-flight entertainment, acoustic research, and virtual reality installations. The company was founded by Brian Conolly and David McGrath in 1991 and is headquartered in Sydney, Australia.

Monash University operates as a public research university. It specializes in higher education, global engagement, postgraduate courses, undergraduate study, and PhD research. The company was founded on March 1961 and is headquartered in Clayton, Australia.

Cerylid Biosciences Ltd. is an Australian pharmaceutical company that manufactures pharmaceutical products. The private company is based in Richmond, Australia.

New Zealand Pharmaceuticals Ltd. engages in the manufacture of pharmaceutical intermediates and diagnostic products for pharmaceutical and biotechnology companies. Its products include pharmaceutical intermediates and ingredients, excipients, carbohydrates, dietary supplements, and feed ingredients. The company was founded in 1971 and is headquartered in Palmerston North, New Zealand.

Universal Biosensors Pty Ltd. manufactures diagnostic test systems. Its products include blood glucose monitoring and coagulation testing. The company was founded in 2001 and is headquartered in Rowville, Australia.

Part of GSK Plc, GlaxoSmithKline Investments Pty Ltd. is an Australian company.

Medicines Australia is a non-profit organization which designs, develops, and implements health and industry policies for pharmaceutical industry. It builds and maintains relationships with government for fair reimbursement of medicines to ensure the continuation of a viable medicines industry, administers the Medicines Australia Code of Conduct which sets the standard for the ethical marketing and promotion of prescription medicines, and provides specialist advice to member companies. The organization is headquartered in Deakin, Australia.

Aus Bio Ltd. engages in the development of biotechnology. It specializes in the influenza, respiratory, and diabetes research. The company was founded on March 3, 2000 and is headquartered in Notting Hill, Australia.

SpeeDx Pty Ltd. is a medical diagnostic company focused on the research, development and commercialization of molecular diagnostic detection technologies. It offers various technologies, including MNAzymes, which are multi-component nucleic acid enzymes composed of DNA to be adapted for sensitive and specific multiplexed detection of various target analytes, as well as catalytically modify substrates producing signals to indicate the presence of target; DNAzymes, which are deoxyribozymes or DNA enzymes to catalyze a repertoire of chemical reactions and are used in the sensor/nanotechnology arena, as well as used for human and animal health; and EzyAmp, an isothermal signal amplification cascade that utilizes restriction enzymes. The company was founded by Elisa E. Mokany and Alison V. Todd in 2009 and is headquartered in Eveleigh, Australia.

Talu Ventures Pty Ltd. (Talu Ventures) is a venture capital firm founded by Andrew Jane, Mark Gill, and Jonathan Whitehouse. The firm is headquartered in Queensland, Australia.

Opal Biosciences Ltd. develops antimicrobial and anti-infective products. The company was founded in and is headquartered in South Melbourne, Australia.

Ocaro Pharmaceuticals, Inc. is an American company that focuses on researching, developing, and producing pain medications that are designed to reduce the need for opioids.